PROVENGE 50,000,000 CELLS in 250 ML Injection

RxCUI: 997267
RxNorm name: PROVENGE 50,000,000 CELLS in 250 ML Injection
Display name: PROVENGE 50,000,000 CELLS in 250 ML Injection
Full name: PROVENGE 50,000,000 CELLS in 250 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125197	Provenge	sipuleucel-T	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PROVENGE	SIPULEUCEL-T	Dendreon Pharmaceuticals LLC	8309b497-5d4e-4408-ac0c-2452c11c8a35	2025-10-03	Warnings, Adverse reactions	Exact identifier rxcui: 997267

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
8309b497-5d4e-4408-ac0c-2452c11c8a35	PROVENGE 50,000,000 CELLS in 250 ML Injection [PSN] · 250 ML sipuleucel-T 200000 CELLS/ML Injection [Provenge] [SBD] · Provenge (minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF per 250 ML of Lactated Ringer's) Injection [SY] · Provenge 50,000,000 CELLS per 250 ML Injection [SY]	4	19	These highlights do not include all the information needed to use PROVENGE ® (sipuleucel-T) safely and effectively. See full prescribing information for PROVENGE. PROVENGE ® (sipuleucel-T) Suspension for Intravenous Infusion Initial U.S. Approval: 2010	20251003